1Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease [J]. Nat Rev Immunol,2001,1(2) :147-153.
7Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus[J]. Lupus, 2004,13 (3):168-176.
8Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus[J]. JAMA, 2006,295 (5) : 527-535.
二级参考文献40
1[1]Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI:a disease activity index for lupus patients.Arthritis Rheum,1992,35:630-640.
2[2]Baldwin JL,Storb R,Thamas ED,et al.Bone marrow transplantation in patients with gold-induced marrow aplasa.Arthritis Rheum,1977,20:1043-1048.
3[3]Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease:a consensus report written on behalf of the European league against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant,1997,19: 643-645.
4[4]Hayag MV,Cohen JA,Kerdel JA,et al.Immunoablative high-dose cyclophosphamide without stem cell rescule in a patient with pemphigus vulgaris.J Am Acad Dermatol.2000,43:1065.
5[5]Euler HH,Marmont AM,Bacigalupo A,et al.Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation.Blood,1996,88: 3621.
6[6]Rosen O,Thiel A,Massenkeil G,et al.Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.Arthritis Res.2000,2:327-336.
7[7]Fassas A,Anagnostostopoulos A,Kazis A,et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant, 1997, 20: 631-638.
8[8]Tynadall A, Fassas A, Passweg J, et al. Autologous hemopoietic stem cell transplants for autoimmune disease: feasibility and transplant relate mortality. Bone Marrow Transplant.1999,24:729-34.
9[1]MORTON J I, SIEGEL B V. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice[J]. Proc Natl Acad Sci U S A, 1974, 71(6): 2162-2165.
10[2]IKEHARA S, KAWAMURA M, TAKAO F, et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells[J]. Proc Natl Acad Sci U S A, 1990, 87(21): 8341-8344.
